Prostate stem cell antigen is associated with diffuse-type gastric cancer

  • Published 2008 in Nature Clinical Practice Oncology

Abstract

There was no significant difference in over­ all survival between the cetuximab plus irino­ tecan (n = 648) and the irinotecan alone (n = 650) study groups (10.7 months vs 10.0 months); however, 46.9% of patients in the irinotecan only group received cetuximab after complet­ ing their assigned study regimen, and 87.2% of those who received post­study… (More)
DOI: 10.1038/ncponc1191

Topics

Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.

Slides referencing similar topics